FRONTIER : FReeStyle Libre system use in Ontario among people with diabetes in the IC / ES database—Evidence from real‐world practice: Patients on basal insulin, glucagon‐like peptide 1 receptor agonist or oral therapies

Documenti analoghi

• The spectrum of exogenous insulin requirement in people living with type 1 diabetes: A cross‐sectional analysis
  di: Virginie Messier, et al.
  Pubblicazione: (2026)
• Cost–utility analysis of a flash continuous glucose monitoring system in the management of people with type 2 diabetes mellitus on basal insulin therapy—An Italian healthcare system perspective
  di: Stefano Del Prato, et al.
  Pubblicazione: (2024)
• Effect of iGlarLixi on continuous glucose monitoring—measured time in range in insulin‐naive adults with suboptimally controlled type 2 diabetes
  di: Juan P. Frías, et al.
  Pubblicazione: (2025)
• The daunting task of recruiting insulin‐treated patients living with type 2 diabetes mellitus for intensive lifestyle interventions
  di: Cathy J. Sun, et al.
  Pubblicazione: (2024)
• Practical limitations of complex insulin therapies in type 2 diabetes: Focus on therapy simplification using fixed‐ratio combinations of basal insulin and a glucagon‐like peptide‐1 receptor agonist
  di: Luděk Horváth, et al.
  Pubblicazione: (2025)